Impact Healthcare - Disposal of five non-core care homes
02/07/2024 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240702:nRSB6877Ua&default-theme=true
RNS Number : 6877U Impact Healthcare REIT PLC 02 July 2024
The information contained in this announcement is restricted and is not for
publication, release or distribution in the United States of America, any
member state of the European Economic Area, Canada, Australia, Japan or the
Republic of South Africa.
2 July 2024
Impact Healthcare REIT plc
("Impact" or the "Company" or, together with its subsidiaries, the "Group")
DISPOSAL AT LATEST BOOK VALUE OF FIVE NON-CORE CARE HOMES FOR £8.8 MILLION
The Board of Directors of Impact Healthcare REIT plc (ticker: IHR), the real
estate investment trust which gives investors exposure to a diversified
portfolio of UK healthcare real estate assets, in particular care homes,
announces that as part of its active portfolio management policy the Group has
exchanged contracts for the sale of five non-core care homes for £8.8
million, which is in line with the latest valuation of these homes as at 31
March 2024.
Impact has exchanged on the sale of three care homes in East Yorkshire for a
total consideration of £4.3 million: Ashgrove Care Home, a 56-bed care home
in Cleethorpes; Emmanuel House, a 44-bed care home in Hessle; and Hamshaw
Court, a 45-bed care home in Hull. The purchaser is a local owner and operator
of care homes, and the transaction is subject to re-registration of the care
home operations from the current tenant, Minster Care Management Limited
("Minster"), to the purchaser which requires the approval of the independent
regulator, the Care Quality Commission ("CQC"). Completion is expected during
the third quarter of this year.
In addition to the above disposals, Impact has exchanged and simultaneously
completed on the sale of two care homes for a total consideration of £4.5
million: Eryl Fryn Care Home, a 30-bed care home in Llandudno, Wales; and
Stansty House Care Home, a 73-bed care home in Wrexham. Eryl Fryn Care Home
and Stansty House Care Home were sold to an affiliate of Minster. In assessing
the merits of the transaction with an associate of Minster, the Company
commissioned a second independent valuation, which supported the sale price.
Minster is deemed to be a related party of the Company under the Listing
Rules. The sale of Eryl Fryn Care Home and Stansty House Care Home is a
smaller related party transaction for the purposes of Listing Rule 11.1.10R
and this announcement is therefore made in accordance with Listing Rule
11.1.10R(2)(c).
Impact acquired the five care homes as part of its IPO seed portfolio in May
2017. The homes have either had a history of relative under-performance, have
low EPC scores or are smaller than the ideal size for a care home (the average
size of homes in the Impact portfolio is 56 beds). Following the sales, Impact
will own 135 properties. The disposal of these five homes will help improve
the sustainability performance of the Group's portfolio either by reducing our
exposure to homes with an EPC C or D, or disposing of homes that have higher
CO2e emissions per m2 than the portfolio average (portfolio average 2023: 54kg
CO2e per m2).
Impact has achieved an unlevered IRR on these non-core homes from purchase to
sale of 6.6% per annum. On the whole of the Minster and Croftwood IPO seed
portfolio its unlevered IRR from May 2017 to March 2024 is 10.5% per annum.
Once completed, these transactions will also reduce the Group's exposure to
the Group's largest tenant.
FOR FURTHER INFORMATION, PLEASE CONTACT:
Impact Health Partners LLP Via H/Advisors Maitland
Andrew Cowley
David Yaldron
Jefferies International Limited +44 20 7029 8000
Tom Yeadon tyeadon@jefferies.com
Ollie Nott onott@jefferies.com
Winterflood Securities Limited +44 20 3100 0000
Neil Langford neil.langford@winterflood.com
Joe Winkley joe.winkley@winterflood.com
H/Advisors Maitland (Communications advisor) impacthealth-maitland@h-advisors.global
James Benjamin +44 7747 113 930
Rachel Cohen +44 20 7379 5151
Billy Moran +44 20 7379 5151
The Company's LEI is 213800AX3FHPMJL4IJ53.
Further information on Impact Healthcare REIT is available at
www.impactreit.uk (http://www.impactreit.uk/) .
NOTES:
Impact Healthcare REIT plc acquires, renovates, extends and redevelops high
quality healthcare real estate assets in the UK and lets these assets on
long-term full repairing and insuring leases to high-quality established
healthcare operators which offer good quality care, under leases which provide
the Company with attractive levels of rent cover.
The Company aims to provide shareholders with an attractive sustainable
return, principally in the form of quarterly income distributions and with the
potential for capital and income growth, through exposure to a diversified and
resilient portfolio of UK healthcare real estate assets, in particular care
homes for the elderly.
The Company's dividend policy is to seek to maintain a progressive dividend
that is covered by adjusted earnings.
On this basis, the target total dividend for the year ending 31 December 2024
is 6.95 pence per share((1)), a 0.18 pence increase over the 6.77 pence in
dividends paid or declared per ordinary share for the year ended 31 December
2023.
The Group's Ordinary Shares were admitted to trading on the main market of the
London Stock Exchange, premium segment, on 8 February 2019. The Company is a
constituent of the FTSE EPRA/NAREIT index.
Notes:
((1)) This is a target only and not a profit forecast. There can
be no assurance that the target will be met and it should not be taken as an
indicator of the Company's expected or actual results.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DISSSMESFELSEIW